EA201890424A1 - Получение клеток пигментного эпителия сетчатки - Google Patents
Получение клеток пигментного эпителия сетчаткиInfo
- Publication number
- EA201890424A1 EA201890424A1 EA201890424A EA201890424A EA201890424A1 EA 201890424 A1 EA201890424 A1 EA 201890424A1 EA 201890424 A EA201890424 A EA 201890424A EA 201890424 A EA201890424 A EA 201890424A EA 201890424 A1 EA201890424 A1 EA 201890424A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- pigment epithelium
- epithelium cells
- obtaining cell
- cell pigment
- cells
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system
- C12N5/0621—Eye cells, e.g. cornea, iris pigmented cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/38—Vitamins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/98—Xeno-free medium and culture conditions
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/15—Transforming growth factor beta (TGF-β)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/50—Proteins
- C12N2533/52—Fibronectin; Laminin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/50—Proteins
- C12N2533/54—Collagen; Gelatin
Abstract
Раскрыт способ получения клеток пигментного эпителия сетчатки. Также раскрыты популяции клеток, которые их содержат, и их применения.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562201156P | 2015-08-05 | 2015-08-05 | |
US201562253738P | 2015-11-11 | 2015-11-11 | |
PCT/IL2016/050857 WO2017021973A1 (en) | 2015-08-05 | 2016-08-04 | Preparation of retinal pigment epithelium cells |
Publications (1)
Publication Number | Publication Date |
---|---|
EA201890424A1 true EA201890424A1 (ru) | 2018-06-29 |
Family
ID=56740278
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201890424A EA201890424A1 (ru) | 2015-08-05 | 2016-08-04 | Получение клеток пигментного эпителия сетчатки |
Country Status (11)
Country | Link |
---|---|
US (2) | US11066642B2 (ru) |
EP (2) | EP3331994B1 (ru) |
JP (1) | JP6864670B2 (ru) |
CN (1) | CN108138144A (ru) |
AU (2) | AU2016303632B2 (ru) |
CA (1) | CA2993912A1 (ru) |
DK (1) | DK3331994T3 (ru) |
EA (1) | EA201890424A1 (ru) |
ES (1) | ES2932823T3 (ru) |
PL (1) | PL3331994T3 (ru) |
WO (1) | WO2017021973A1 (ru) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10485829B2 (en) | 2009-11-17 | 2019-11-26 | Astellas Institute For Regenerative Medicine | Methods of producing human RPE cells and pharmaceutical preparations of human RPE cells |
JP6882981B2 (ja) | 2014-12-30 | 2021-06-02 | セル キュア ニューロサイエンシズ リミテッド | Rpe細胞集団およびそれを作製する方法 |
EP3595687A1 (en) | 2017-03-16 | 2020-01-22 | Lineage Cell Therapeutics, Inc. | Methods for measuring therapeutic effects of retinal disease therapies |
BR112020013238A2 (pt) * | 2017-12-29 | 2020-12-01 | Cell Cure Neurosciences Ltd. | composição e método para formular células do epitélio pigmentar da retina bem como uso da dita composição para tratar uma condição retiniana |
JP2022532411A (ja) * | 2019-05-15 | 2022-07-14 | ノヴォ ノルディスク アー/エス | ヒト多能性幹細胞から眼野前駆細胞を得るための方法 |
EP3754014A1 (en) | 2019-06-21 | 2020-12-23 | Centre d'Etude des Cellules Souches (CECS) | Automated method for preparing retinal pigment epithelium cells |
CN112544612A (zh) * | 2020-12-18 | 2021-03-26 | 江苏艾尔康生物医药科技有限公司 | 冻存液及其在rpe细胞冻存中的应用 |
EP4351334A1 (en) | 2021-06-09 | 2024-04-17 | Lineage Cell Therapeutics, Inc. | Methods and compositions for treating retinal diseases and conditions |
CN113481158A (zh) * | 2021-06-24 | 2021-10-08 | 暨南大学 | 一种无支架视网膜色素上皮细胞片的制备方法 |
KR20240038013A (ko) | 2021-07-28 | 2024-03-22 | 리니지 셀 테라퓨틱스, 인크. | 망막 색소 상피 세포의 확장 |
WO2023167986A1 (en) | 2022-03-02 | 2023-09-07 | Lineage Cell Therapeutics, Inc. | Methods and compositions for treating hearing loss |
WO2023211857A1 (en) | 2022-04-25 | 2023-11-02 | Lineage Cell Therapeutics, Inc. | Methods and compositions for treating vision loss |
Family Cites Families (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL154600B (nl) | 1971-02-10 | 1977-09-15 | Organon Nv | Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen. |
NL154598B (nl) | 1970-11-10 | 1977-09-15 | Organon Nv | Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking. |
NL154599B (nl) | 1970-12-28 | 1977-09-15 | Organon Nv | Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen, alsmede testverpakking. |
US3901654A (en) | 1971-06-21 | 1975-08-26 | Biological Developments | Receptor assays of biologically active compounds employing biologically specific receptors |
US3853987A (en) | 1971-09-01 | 1974-12-10 | W Dreyer | Immunological reagent and radioimmuno assay |
US3867517A (en) | 1971-12-21 | 1975-02-18 | Abbott Lab | Direct radioimmunoassay for antigens and their antibodies |
NL171930C (nl) | 1972-05-11 | 1983-06-01 | Akzo Nv | Werkwijze voor het aantonen en bepalen van haptenen, alsmede testverpakkingen. |
US3850578A (en) | 1973-03-12 | 1974-11-26 | H Mcconnell | Process for assaying for biologically active molecules |
US3935074A (en) | 1973-12-17 | 1976-01-27 | Syva Company | Antibody steric hindrance immunoassay with two antibodies |
US3996345A (en) | 1974-08-12 | 1976-12-07 | Syva Company | Fluorescence quenching with immunological pairs in immunoassays |
US4034074A (en) | 1974-09-19 | 1977-07-05 | The Board Of Trustees Of Leland Stanford Junior University | Universal reagent 2-site immunoradiometric assay using labelled anti (IgG) |
US3984533A (en) | 1975-11-13 | 1976-10-05 | General Electric Company | Electrophoretic method of detecting antigen-antibody reaction |
US4098876A (en) | 1976-10-26 | 1978-07-04 | Corning Glass Works | Reverse sandwich immunoassay |
US4879219A (en) | 1980-09-19 | 1989-11-07 | General Hospital Corporation | Immunoassay utilizing monoclonal high affinity IgM antibodies |
US5011771A (en) | 1984-04-12 | 1991-04-30 | The General Hospital Corporation | Multiepitopic immunometric assay |
US4666828A (en) | 1984-08-15 | 1987-05-19 | The General Hospital Corporation | Test for Huntington's disease |
US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
US4801531A (en) | 1985-04-17 | 1989-01-31 | Biotechnology Research Partners, Ltd. | Apo AI/CIII genomic polymorphisms predictive of atherosclerosis |
US5272057A (en) | 1988-10-14 | 1993-12-21 | Georgetown University | Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase |
SG49267A1 (en) | 1989-08-14 | 1998-05-18 | Photogenesis Inc | Surgical instrument and cell isolation and transplantation |
US5192659A (en) | 1989-08-25 | 1993-03-09 | Genetype Ag | Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes |
US6045791A (en) | 1992-03-06 | 2000-04-04 | Photogenesis, Inc. | Retinal pigment epithelium transplantation |
US5281521A (en) | 1992-07-20 | 1994-01-25 | The Trustees Of The University Of Pennsylvania | Modified avidin-biotin technique |
US5755785A (en) | 1994-08-12 | 1998-05-26 | The University Of South Florida | Sutureless corneal transplantation method |
US5843780A (en) | 1995-01-20 | 1998-12-01 | Wisconsin Alumni Research Foundation | Primate embryonic stem cells |
US5941250A (en) | 1996-11-21 | 1999-08-24 | University Of Louisville Research Foundation Inc. | Retinal tissue implantation method |
US6090622A (en) | 1997-03-31 | 2000-07-18 | The Johns Hopkins School Of Medicine | Human embryonic pluripotent germ cells |
GB9715584D0 (en) | 1997-07-23 | 1997-10-01 | Eisai Co Ltd | Compounds |
GB0001930D0 (en) | 2000-01-27 | 2000-03-22 | Novartis Ag | Organic compounds |
SK8792003A3 (en) | 2001-01-31 | 2004-09-08 | Pfizer Prod Inc | Nicotinamide biaryl derivatives useful as inhibitors of PDE4 isozymes and pharmaceutical composition containing them |
AU2003201745A1 (en) | 2002-02-11 | 2003-09-04 | Pfizer Limited | Nicotinamide derivatives and a tiotropium salt in combination for the treatment of e.g. inflammatory, allergic and respiratory diseases |
US7267981B2 (en) | 2002-10-07 | 2007-09-11 | Technion Research & Development Foundation Ltd. | Human foreskin fibroblasts for culturing ES cells |
TWI280239B (en) | 2003-07-15 | 2007-05-01 | Hoffmann La Roche | Process for preparation of pyridine derivatives |
WO2006040763A2 (en) | 2004-10-12 | 2006-04-20 | Technion Research & Development Foundation Ltd. | Isolated primate embryonic cells and methods of generating and using same |
EP1844136B1 (en) | 2004-12-29 | 2014-08-27 | Hadasit Medical Research Services And Development Ltd. | Stem cells culture systems |
US9133435B2 (en) | 2007-01-18 | 2015-09-15 | Riken | Method for induction/differentiation into photoreceptor cell |
JP5395058B2 (ja) | 2007-04-18 | 2014-01-22 | ハダシット メディカル リサーチ サーヴィシーズ アンド ディヴェロップメント リミテッド | 幹細胞に由来する網膜色素上皮細胞 |
ES2542226T3 (es) * | 2010-04-28 | 2015-08-03 | Technische Universität Dresden | Método para producir células progenitoras retinianas polarizadas a partir de células madre pluripotentes y su diferenciación para dar células del epitelio pigmentario retiniano |
DK2785359T3 (en) * | 2011-11-30 | 2018-10-29 | Astellas Inst For Regenerative Medicine | MESENKYMAL STROMACELLES AND APPLICATIONS RELATED |
US9658216B2 (en) | 2012-01-31 | 2017-05-23 | Cell Cure Neurosciences Ltd. | Methods of selecting retinal pigmented epithelial cells |
US9850463B2 (en) | 2012-02-01 | 2017-12-26 | The Regents Of The University Of California | Methods of culturing retinal pigmented epithelium cells, including xeno-free production, RPE enrichment, and cryopreservation |
EP2882846B1 (en) | 2012-06-05 | 2018-09-05 | The Regents of the University of California | Methods and compositions for the rapid production of retinal pigmented epithelial cells from pluripotent cells |
AU2014212230B2 (en) | 2013-02-01 | 2019-07-04 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Method for generating retinal pigment epithelium (RPE) cells from induced pluripotent stem cells (iPSCs) |
AU2014363032A1 (en) | 2013-12-11 | 2016-06-09 | Pfizer Limited | Method for producing retinal pigment epithelial cells |
WO2016108240A1 (en) * | 2014-12-30 | 2016-07-07 | Cell Cure Neurosciences Ltd. | Assessing retinal pigment epithelial cell populations |
JP6882981B2 (ja) | 2014-12-30 | 2021-06-02 | セル キュア ニューロサイエンシズ リミテッド | Rpe細胞集団およびそれを作製する方法 |
US11230696B2 (en) | 2015-07-29 | 2022-01-25 | Hadasit Medical Research Services And Development Ltd. | Large scale production of retinal pigment epithelial cells |
-
2016
- 2016-08-04 AU AU2016303632A patent/AU2016303632B2/en active Active
- 2016-08-04 ES ES16753990T patent/ES2932823T3/es active Active
- 2016-08-04 CN CN201680058625.0A patent/CN108138144A/zh active Pending
- 2016-08-04 WO PCT/IL2016/050857 patent/WO2017021973A1/en active Application Filing
- 2016-08-04 EP EP16753990.7A patent/EP3331994B1/en active Active
- 2016-08-04 EP EP22193431.8A patent/EP4155391A1/en active Pending
- 2016-08-04 CA CA2993912A patent/CA2993912A1/en active Pending
- 2016-08-04 US US15/750,108 patent/US11066642B2/en active Active
- 2016-08-04 PL PL16753990.7T patent/PL3331994T3/pl unknown
- 2016-08-04 JP JP2018505671A patent/JP6864670B2/ja active Active
- 2016-08-04 DK DK16753990.7T patent/DK3331994T3/da active
- 2016-08-04 EA EA201890424A patent/EA201890424A1/ru unknown
-
2021
- 2021-06-22 US US17/355,093 patent/US20210388316A1/en active Pending
-
2022
- 2022-12-20 AU AU2022291461A patent/AU2022291461A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
EP4155391A1 (en) | 2023-03-29 |
CA2993912A1 (en) | 2017-02-09 |
US20210388316A1 (en) | 2021-12-16 |
AU2016303632A1 (en) | 2018-02-08 |
EP3331994B1 (en) | 2022-09-14 |
PL3331994T3 (pl) | 2023-01-30 |
CN108138144A (zh) | 2018-06-08 |
AU2016303632B2 (en) | 2022-09-29 |
AU2022291461A1 (en) | 2023-02-02 |
JP6864670B2 (ja) | 2021-04-28 |
DK3331994T3 (da) | 2022-11-21 |
WO2017021973A1 (en) | 2017-02-09 |
US11066642B2 (en) | 2021-07-20 |
JP2018521678A (ja) | 2018-08-09 |
ES2932823T3 (es) | 2023-01-26 |
US20180230426A1 (en) | 2018-08-16 |
EP3331994A1 (en) | 2018-06-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201890424A1 (ru) | Получение клеток пигментного эпителия сетчатки | |
MX2017006127A (es) | Metodos y composiciones para produccion de proteina de clara de huevo. | |
CL2018002852A1 (es) | Producción celular de ácido ribonucleico | |
CL2016002455A1 (es) | Anticuerpos multiespecíficos. | |
EA201692425A1 (ru) | Модифицированные биополимеры и способы их получения и использования | |
HK1251249A1 (zh) | 用於製備視網膜色素上皮細胞的方法 | |
EP3313460A4 (en) | FABRICS AND METHODS OF MAKING SAME FROM CULTIVATED CELLS | |
WO2016054615A3 (en) | Targeted augmentation of nuclear gene output | |
BR112016018105A2 (pt) | célula eletroquímica, método de produção de uma célula eletroquímica | |
MX2016007671A (es) | Metodo para producir celulas del epitelio pigmentario retiniano. | |
EA201890442A1 (ru) | Получение фоторецепторов для лечения заболеваний сетчатки | |
EP3594322A4 (en) | RETINAL PIGMENTARY EPITHELIAL CELL PRODUCTION PROCESS | |
MY180732A (en) | Protein manufacture | |
IL257148A (en) | Large-scale production of retinal pigment epithelial cells | |
MX2021008663A (es) | Anticuerpos mejorados contra il-6. | |
MY193444A (en) | Cell-free production of ribonucleic acid | |
EP3380611A4 (en) | PRODUCTION OF VIRUSES IN A CELL CULTURE | |
EA201892060A1 (ru) | Микробная продукция рибозида никотиновой кислоты | |
AR112226A1 (es) | Comprimidos preparados por compresión | |
UY34543A (es) | Derivados de sulfonilaminopirrolidinona, su preparación y aplicación terapéutica. | |
EP4008343A3 (en) | Methods and compositions related to increased viral production | |
MX2016013586A (es) | Tinturas reactivas fluorescentes, proceso para su produccion y su uso. | |
IN2014CH00304A (ru) | ||
EP3194573A4 (en) | Mammalian pluripotent stem cells, methods for their production, and uses thereof | |
MX2019006783A (es) | Procedimiento para la preparacion de 4-amino-1-( (1s, 4r, 5s) -2-fluoro-4,5-dihidroxi-3-hidroximetil-ciclopent-2-enil)-1h-pirim idin-2-ona. |